Impaired liver-muscle lactate metabolism causes sarcopenia via lactic acidosis in skeletal muscle in mice
Science Advances · 2026
DOI: 10.1126/sciadv.aeb4011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Takahiro Eguchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Brain-Skeletal Muscle Connection in Aging Project Team, Geroscience Research Center, National Center for Geriatrics and Gerontology, Obu, Japan. Hauptthemen laut MEDLINE: Acidosis, Lactic, Muscle, Skeletal, Sarcopenia, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Takeda Science Foundation, Grant-in-Aid for Challenging Research, JST FOREST Program.
Abstract (Originalsprache)
Sarcopenia is a progressive disease characterized by age-related decline in skeletal muscle force and mass. The fundamental molecular pathogenesis of sarcopenia has not yet been elucidated. Here, we show that the accumulation of lactate and intracellular acidification, lactic acidosis, in skeletal muscle owing to impaired liver-skeletal muscle lactate metabolism is the fundamental cause of sarcopenia. Systemic lactate tolerance decreased in aged mice owing to the impaired lactate processing capacity in the liver, which caused lactic acidosis in skeletal muscle. Furthermore, pharmacological activation of hypoxia-inducible factor (HIF) or liver-specific activation of HIF1α improved age-associated impairment in lactate tolerance, lactic acidosis in skeletal muscle, and sarcopenia. Mechanistically, the decreased nicotinamide adenine dinucleotide level was the cause of dysregulated skeletal muscle functions due to lactic acidosis. Using mouse models, our results show lactic acidosis in skeletal muscle as a key molecular pathogenesis of sarcopenia and highlight HIF1α in the liver as a pharmacological target for sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brain-Skeletal Muscle Connection in Aging Project Team, Geroscience Research Center, National Center for Geriatrics and Gerontology, Obu, Japan.
- Juntendo Advanced Research Institute for Health Science, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Japan.
- Shonai Regional Industry Promotion Center, Tsuruoka, Japan.
- Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
- Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
ORCID-Profile: Takahiro Eguchi, Nozomi Hayashiji, Sho Tabata, Yasunori Shintani, Hideki Makinoshima, Naoki Ito
Förderung
- Takeda Science Foundation
- Grant-in-Aid for Challenging Research
- JST FOREST Program
- The Japan Health Research Promotion Bureau
- THE HORI SCIENCE AND ARTS FOUNDATION
- the Research and Development Grants for Longevity Science
- the Research Fund for Longevity Sciences from the NCGG
- the Naito Foundation Next Generation Support research grant
Zitieren
APA
Eguchi, T., Hayashiji, N., Tabata, S., Kabetani, K., Shintani, Y., Makinoshima, H., & Ito, N. (2026). Impaired liver-muscle lactate metabolism causes sarcopenia via lactic acidosis in skeletal muscle in mice. Science Advances. https://doi.org/10.1126/sciadv.aeb4011
Vancouver
Eguchi T, Hayashiji N, Tabata S, Kabetani K, Shintani Y, Makinoshima H, et al. Impaired liver-muscle lactate metabolism causes sarcopenia via lactic acidosis in skeletal muscle in mice. Science Advances. 2026. doi:10.1126/sciadv.aeb4011
BibTeX
@article{Eguchi2026,
author = {Eguchi, Takahiro and Hayashiji, Nozomi and Tabata, Sho and Kabetani, Keiko and Shintani, Yasunori and Makinoshima, Hideki and Ito, Naoki},
title = {Impaired liver-muscle lactate metabolism causes sarcopenia via lactic acidosis in skeletal muscle in mice},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeb4011}
}
EUVIMED